Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review

被引:19
作者
Gu, Xiaoling [1 ]
Ma, Chunyan [1 ]
Yuan, Dongmei [1 ]
Song, Yong [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China
关键词
Intercellular adhesion molecule; lung cancer; prognosis; systematic review;
D O I
10.3978/j.issn.2218-6751.08.01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Soluble intercellular adhesion molecule-1 (sICAM-1) has been implicated in tumor progression and metastasis. However the expression of circulating sICAM-1 as well as its diagnostic and prognostic value in patients with lung cancer remains controversial. We performed an electronic database (including PubMed, Web of Science, and Medline) search with the terms "ICAM", " intercellular adhesion molecule" and " lung cancer", and summarized the results of eligible studies in order to review the expression of sICAM-1 as well as its clinical significance in lung cancer. According to our literature search, we conducted a final analysis of 1258 patients from 16 studies. And we revealed that the circulating concentration of sICAM-1 in lung cancer patients was significantly higher than that in healthy controls. Additionally, baseline sICAM-1 levels apparently were associated with ECOG performance status, gender, histology type and disease stages. Furthermore, there seems to be a significantly inverse association between sICAM-1 levels, prognosis and response rate in NSCLC patients. In conclusion, sICAM-1 appeared to be a potential diagnostic and prognostic biomarker in lung cancer patients. Additional prospective studies are required to confirm this issue.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 35 条
  • [1] Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery
    Alexiou, D
    Karayiannakis, AJ
    Syrigos, KN
    Zbar, A
    Kremmyda, A
    Bramis, I
    Tsigris, C
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (18) : 2392 - 2397
  • [2] THE BINDING-SITE ON ICAM-1 FOR PLASMODIUM-FALCIPARUM INFECTED ERYTHROCYTES OVERLAPS, BUT IS DISTINCT FROM, THE LFA-1-BINDING SITE
    BERENDT, AR
    MCDOWALL, A
    CRAIG, AG
    BATES, PA
    STERNBERG, MJE
    MARSH, K
    NEWBOLD, CI
    HOGG, N
    [J]. CELL, 1992, 68 (01) : 71 - 81
  • [3] ICAM- MELANOMA-CELLS ARE RELATIVELY RESISTANT TO CD3-MEDIATED T-CELL LYSIS
    BRAAKMAN, E
    GOEDEGEBUURE, PS
    VREUGDENHIL, RJ
    SEGAL, DM
    SHAW, S
    BOLHUIS, RLH
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (03) : 475 - 480
  • [4] De Vita F, 1998, ONCOL REP, V5, P393
  • [5] Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab - an eastern cooperative oncology group study
    Dowlati, Afshin
    Gray, Robert
    Sandler, Alan B.
    Schiller, Joan H.
    Johnson, David H.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1407 - 1412
  • [6] CIRCULATING ADHESION MOLECULES IN DISEASE
    GEARING, AJH
    NEWMAN, W
    [J]. IMMUNOLOGY TODAY, 1993, 14 (10): : 506 - 512
  • [7] Gho YS, 2001, CANCER RES, V61, P4253
  • [8] Gho YS, 1999, CANCER RES, V59, P5128
  • [9] Soluble Adhesion Molecules E-Cadherin, Intercellular Adhesion Molecule-1, and E-Selectin as Lung Cancer Biomarkers
    Gogali, Athena
    Charalabopoulas, Konstantinos
    Zampira, Iris
    Konstantinidis, Athanasios K.
    Tachmazoglou, Fanny
    Daskalopoulos, George
    Constantopoulas, Stavros H.
    Dalavanga, Yotanna
    [J]. CHEST, 2010, 138 (05) : 1173 - 1179
  • [10] Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage
    Grothey, A
    Heistermann, P
    Philippou, S
    Voigtmann, R
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (05) : 801 - 807